Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Starr

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Acta Neuropathologica|April 5, 2019
ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTDStephen Moore, Eric Alsop, Ileana Lorenzini, et al.
Breast Cancer Research : BCR|April 19, 2015
Quantitative measurement of HER2 expression in breast cancers: comparison with 'real-world' routine HER2 testing in a multicenter Collaborative Biomarker Study and correlation with overall survivalDenise A Yardley, Peter A Kaufman, Weidong Huang, et al.
Neurobiology of Disease|December 28, 2020
The M1311V variant of ATP7A is associated with impaired trafficking and copper homeostasis in models of motor neuron diseaseNadine Bakkar, Alexander Starr, Benjamin E Rabichow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2013
Sorafenib or placebo with either gemcitabine or capecitabine in patients with HER-2-negative advanced breast cancer that progressed during or after bevacizumabLee S Schwartzberg, Kurt W Tauer, Robert C Hermann, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Acta Neuropathologica|April 5, 2019
ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTDStephen Moore, Eric Alsop, Ileana Lorenzini, et al.
Breast Cancer Research : BCR|April 19, 2015
Quantitative measurement of HER2 expression in breast cancers: comparison with 'real-world' routine HER2 testing in a multicenter Collaborative Biomarker Study and correlation with overall survivalDenise A Yardley, Peter A Kaufman, Weidong Huang, et al.
Neurobiology of Disease|December 28, 2020
The M1311V variant of ATP7A is associated with impaired trafficking and copper homeostasis in models of motor neuron diseaseNadine Bakkar, Alexander Starr, Benjamin E Rabichow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2013
Sorafenib or placebo with either gemcitabine or capecitabine in patients with HER-2-negative advanced breast cancer that progressed during or after bevacizumabLee S Schwartzberg, Kurt W Tauer, Robert C Hermann, et al.
Pageof 2